Journal article
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
EUROPEAN CARDIOLOGY REVIEW, Vol.15, pp.41-42
02/2020
DOI: 10.15420/ecr.2019.1.3
PMCID: PMC7066827
PMID: 32180832
Abstract
Although there are abundant data highlighting the safety and efficacy of direct oral anticoagulants, to date, recent guidelines have limited their use to stroke prevention in patients with non-valvular AF, as well as in the prevention and treatment of venous thromboembolism and pulmonary embolism. Encouraging data about the off-label use of direct oral anticoagulants have been shown in several other indications, such as intracardiac thrombi, left ventricular thrombi and left atrial appendage, but a large sector of patients are still not addressed, such as valvular and prosthetic patients.
Details
- Title: Subtitle
- Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
- Creators
- Mahmoud Abdelnabi - Alexandria UniversityAbdallah Almaghraby - Alexandria UniversityYehia Saleh - Michigan State University
- Resource Type
- Journal article
- Publication Details
- EUROPEAN CARDIOLOGY REVIEW, Vol.15, pp.41-42
- DOI
- 10.15420/ecr.2019.1.3
- PMID
- 32180832
- PMCID
- PMC7066827
- NLM abbreviation
- Eur Cardiol
- ISSN
- 1758-3756
- eISSN
- 1758-3764
- Publisher
- Radcliffe Cardiology
- Number of pages
- 2
- Language
- English
- Date published
- 02/2020
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984755385702771
Metrics
4 Record Views